诺和诺德Novo Nordisk (NVO) 2005年年度报告「NYSE」.pdf

1、pursuingthe visionbusiness resultsdiabetes carebiopharmaceuticalschallenging workplacevalues in actionperformancehighlights consolidated financial and non-financial statements 2005 spotlight onaccess to healthinnovationglobalisationbusiness ethicsfinancial,social&environmental performance 2005hownov

2、o nordisk is changing diabetes228This is Novo Nordisks Annual Report 2005.Itaccounts for the companys performance dur-ing the year and discusses key challenges.Itpresents the strategic initiatives to develop thebusiness in order to meet its targets and sus-tain long-term value creation.And it explai

3、nsNovo Nordisks way of doing business as a values-based company guided by a vision.The vision sets the direction and aims to in-spire everyone at Novo Nordisk to make theircontribution to shaping the future for thecompany:achieving competitive business re-sults,defending the companys leadership indi

4、abetes care,offering innovative productsand services in biopharmaceuticals,makingthe company a challenging workplace andputting values into action.Each of the visionstatements translates into short-and medium-term targets throughout the organisation.Opportunities and challengesThe feature articles a

5、re organised under the visions five headings,and present the key opportunities and challenges for Novo Nordiskas a global healthcare company.They presentcompany-driven activities in pursuit of theNovo Nordisk vision and strategic objectives,and respond to concerns identified throughinteractions with

6、 shareholders,financial ana-lysts and other stakeholders during the year.These topics have been identified as materialfor readers valuation of the companys posi-tion for the future.Four challenges stand out as particularlycritical to address:access to health for every-one,innovation in the pharmaceu